Neuroimaging – News and Features

Siemens’ Molecular Imaging research facility is dedicated to the development of molecular imaging biomarkers for identifying debilitating diseases at their earliest stages.

An MIT professor and her colleagues have created nanoparticles that mimic blood platelets.

The UAB SeRMN to install a Bruker BIOSPEC 70/30 and a Bruker AvanceII 600 spectrometers for nuclear magnetic resonance.

The PDC allocates funds to a 7,000 square foot R&D facility in Portland for development and manufacturing of QuantRx lateral flow devices.

The compound developed by UCLA, called FDDNP, holds promise as a research tool to evaluate treatments for Alzheimer's.

Dr. Richard receives a $15 million, five-year grant to continue operating the Coordinating and Bioinformatics Unit.

Study results show that accurate in vivo quantitation of drug distribution and therapeutic effect is possible.

The grant will fund research in which two or more medical imaging techniques are combined to provide complementary information.

Data suggest the potential for targeting the key proteins, RANK Ligand and sclerostin, for bone loss conditions.

Kroto, a professor in the School of Chemistry and Molecular Sciences at the University of Sussex, will speak on "Architecture in NanoSpace."